African health ministers endorse new strategy to curb chronic disease crisis

The strategy supports building the capacity of district hospitals and other first-level referral facilities to diagnose and manage severe noncommunicable diseases early, resulting in fewer deaths

0
224

With the burden of cardiovascular disease, mental and neurological disorders and diabetes rising in the region, African health ministers have endorsed a new strategy to boost access to the diagnosis, treatment and care of severe noncommunicable diseases.

The health ministers, gathering for the Seventy-second session of the World Health Organization (WHO) Regional Committee for Africa in Lomé, Togo, adopted the strategy known as PEN-PLUS, A Regional Strategy to Address Severe Noncommunicable Diseases at First-Level Referral Health Facilities.

The strategy supports building the capacity of district hospitals and other first-level referral facilities to diagnose and manage severe noncommunicable diseases early, resulting in fewer deaths.

Severe noncommunicable diseases are those chronic conditions that lead to high levels of disability and death among children, adolescents and young adults if left undiagnosed or untreated. In the worst cases, patients live no longer than a year after diagnosis.

In Africa, the most prevalent severe noncommunicable diseases include sickle cell disease, type 1 and insulin-dependent type 2 diabetes, rheumatic heart disease, cardiomyopathy, severe hypertension and moderate to severe and persistent asthma.

“Africa is grappling with an increasingly hefty burden of chronic diseases whose severe forms are costing precious lives that could be saved with early diagnosis and care,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “The strategy adopted today is pivotal in placing effective care within the reach of patients and marks a major step in improving the health and wellbeing of millions of people in the region.”

In most parts of Africa, severe noncommunicable diseases are treated at tertiary health facilities, which are mostly in large cities. This exacerbates health inequities, as it puts care beyond the reach of most rural, peri-urban and lower-income patients, who can often only easily access district hospitals and local health centres. These facilities lack the capacity and resources to effectively manage severe noncommunicable diseases.

Africa is grappling with an increasingly hefty burden of chronic diseases whose severe forms are costing precious lives that could be saved with early diagnosis and care

The strategy adopted today urges countries to institute standardized programmes to tackle chronic and severe noncommunicable diseases by ensuring that essential medicines, technologies and diagnostics are available and accessible at district hospitals.

Only 36 per cent of countries in the African region reported having essential medicines for noncommunicable diseases in public hospitals, according to a 2019 WHO survey. Governments should also ensure that people seeking care in private hospitals can access services for severe noncommunicable diseases.

Additionally, countries should bolster the protocols for prevention, care and treatment of chronic noncommunicable diseases through training and strengthening the skills and knowledge of health workers.

Noncommunicable diseases account for most of the out-of-pocket spending of patients in Africa and due to their chronic nature often led to catastrophic health expenditures. By offering noncommunicable disease care as a package of services available at primary and district health facilities, patients will find their expenses decrease as they spend less money on transportation, lodging in cities and less time commuting to the health facilities.

The PEN-PLUS strategy adopted today builds on existing WHO initiatives for integrated detection, diagnosis, treatment, and care of noncommunicable diseases in primary health care facilities.

It has shown promising results in Liberia, Malawi, and Rwanda, with a significant increase in the number of patients accessing treatment for severe noncommunicable diseases and, a concomitant improvement in outcomes for these patients.

LEAVE A REPLY

Please enter your comment!
Please enter your name here